{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:21:04Z","timestamp":1780395664943,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13256-017-1462-5","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T19:11:23Z","timestamp":1509649883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Aviva","family":"Cohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,12]]},"reference":[{"issue":"5","key":"1462_CR1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diabet.2013.03.002","volume":"39","author":"F Rajas","year":"2013","unstructured":"Rajas F, Labrune P, Mithieux G. Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders. Diabetes Metab. 2013;39(5):377\u201387.","journal-title":"Diabetes Metab"},{"issue":"3","key":"1462_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10545-014-9761-0","volume":"38","author":"F Rajas","year":"2015","unstructured":"Rajas F, et al. Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease. J Inherit Metab Dis. 2015;38(3):521\u20137.","journal-title":"J Inherit Metab Dis"},{"key":"1462_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-6-27","volume":"6","author":"R Froissart","year":"2011","unstructured":"Froissart R, et al. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis. 2011;6:27.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1462_CR4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1515\/JPEM.2005.18.6.617","volume":"18","author":"R Spiegel","year":"2005","unstructured":"Spiegel R, et al. Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. J Pediatr Endocrinol Metab. 2005;18(6):617\u201320.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"1462_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13023-015-0301-2","volume":"10","author":"D Melis","year":"2015","unstructured":"Melis D, et al. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. Orphanet J Rare Dis. 2015;10(1):91.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"1462_CR6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/diab.18.11.755","volume":"18","author":"DH Lockwood","year":"1969","unstructured":"Lockwood DH, et al. Insulin secretion in type I glycogen storage disease. Diabetes. 1969;18(11):755\u20138.","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"1462_CR7","first-page":"S77","volume":"35","author":"A Sechi","year":"2012","unstructured":"Sechi A, Ellerton C, Peters C, Gissen P, Mundy H, Lachmann RH, Murphy E. Insulin resistance and diabetes in glycogen storage disease: presentation of 5 clinical cases. J Inherit Metab Dis. 2012;35 Suppl 1:S77.","journal-title":"J Inherit Metab Dis"},{"key":"1462_CR8","unstructured":"Bali DS, Chen YT, Austin S, et al. Glycogen storage disease type I. 2006 Apr 19 (Updated 2016 Aug 25). In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews\u00ae [Internet]. Seattle: University of Washington; 1993-2017. Available from: \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1312\/\n\n."},{"issue":"7503","key":"1462_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry RJ, et al. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510(7503):84\u201391.","journal-title":"Nature"},{"issue":"2","key":"1462_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103(2):71\u201383.","journal-title":"QJM"},{"issue":"3","key":"1462_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3945\/an.112.002089","volume":"3","author":"MC Moore","year":"2012","unstructured":"Moore MC, et al. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr. 2012;3(3):286\u201394.","journal-title":"Adv Nutr"},{"issue":"4","key":"1462_CR12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/193229680900300439","volume":"3","author":"M Riddell","year":"2009","unstructured":"Riddell M, Perkins BA. Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring. J Diabetes Sci Technol. 2009;3(4):914\u201323.","journal-title":"J Diabetes Sci Technol"},{"key":"1462_CR13","volume-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","author":"Y Handelsman","year":"2016","unstructured":"Handelsman Y, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. 2016."},{"issue":"8","key":"1462_CR14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2337\/diacare.14.8.732","volume":"14","author":"M Hanefeld","year":"1991","unstructured":"Hanefeld M, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care. 1991;14(8):732\u20137.","journal-title":"Diabetes Care"},{"key":"1462_CR15","unstructured":"King MW. GSD1 Microbiology. New York: AccessPharmacy, McGraw-Hill Education; 2014. \nwww.accesspharmacy.mhmedical.com\/data\/books\/1696\/kin_ch14_f008.png\n\n."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-017-1462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T19:11:36Z","timestamp":1509649896000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-017-1462-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1186\/s13256-017-1462-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,12]]},"article-number":"319"}}